Neurol. praxi. 2019;20(3):190-194 | DOI: 10.36290/neu.2019.017

Diagnostics algorithm of muscular dystrophies

MUDr. Radim Mazanec, Ph.D.1, MUDr. Lívie Mensová1, MUDr. Daniel Baumgartner1, MUDr. Veronika Potočková1, prof. MUDr. Josef Zámečník, Ph.D.2
1 Neurologická klinika 2. LF UK a FN Motol, Praha
2 Ústav patologie a molekulární mediciny 2. LF UK a FN Motol, Praha

The diagnostics algorithm of muscular dystrophies has changed significantly over the past decade, mainly due to the development and increase of availability of molecular genetics and imaging methods. The golden standard of detailed medical history, attentive clinical examination, biochemical and electrophysiological testing now includes also magnetic resonance imaging and targeted or more extensive molecular genetic examinations, while muscle biopsy ceased to be the first choice method in the diagnostic process of hereditary myopathies. Routine MRI performance in patients with muscle. dystrophies allowed the detection and description of patterns of recognition characteristic for certain clinical units. Molecular genetic examinations as the only one allow definitive diagnosis to be determined by causal mutation detection. For better orientation in common outpatient practice, the article describes the crucial steps leading to the discovery of individual types of muscular dystrophy with respect to the level of today's knowledge and experience.

Keywords: muscular dystrophy, myopathy, hyperCKaemia, myogenic lesions, pattern of recognition

Received: February 15, 2019; Accepted: March 1, 2019; Prepublished online: March 1, 2019; Published: June 12, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mazanec R, Mensová L, Baumgartner D, Potočková V, Zámečník J. Diagnostics algorithm of muscular dystrophies. Neurol. praxi. 2019;20(3):190-194. doi: 10.36290/neu.2019.017.
Download citation

References

  1. Berrardo A, DiMauro S, Hirano M. A Diagnostic Algorhitm for Metabolic Myopathies. Curr Neurol Neurosci Rep. 2010; 10(2): 118-126. Go to original source... Go to PubMed...
  2. Fugelsang-Frederiksen A. The role of different EMG methods in evaluating myopathy. Clin Neurophysiol. 2006; 117(6): 1173-1189. Go to original source...
  3. Kyriakides T, Angelini C, Schaefer J, Sacconi S, Siciliano G, Vilchez JJ, Hilton-Jones D. EFNS guidelines on the diagnostic approach to pauci-or asymptomatic hyperCKemia. EurJNeurol 2010; 17: 767-773. Go to original source... Go to PubMed...
  4. Mensová L, Parmová O. Celonárodní screening Pompeho nemoci u pacientů s nespecifikovanou svalovou slabostí, hyperCKémií a respirační insuficiencí. Neurol. praxi 2018; 19(4): 306-308.
  5. Paganoni S, Amato A. Electrodiagnostic Evaluation of Myopathies. Phys Med RehabilClin N Am 2013; 24(1): 193-207. Go to original source... Go to PubMed...
  6. Schoser B. Klinische Phänotypen hereditärer Myopathien und die Indikazion zur Muskelbiopsie. Akt Neurol 2009; 36: 221-226. Go to original source...
  7. Straub V, Carlier PG, Mercuri E. TREAT-NMD workshop: Pattern recognition in genetic muscle diseases using muscle MRI. Neuromuscular Disorders. 2012; 22: S42-S53. DOI: 10.1016/j.nmd.2012.08.002. ISSN 09608966. Go to original source... Go to PubMed...
  8. Wattjes MP, Fischer D. Neuromuscular imaging. New York: Springer, 2013. ISBN 978-1-4614-6551-5. Go to original source...
  9. Zámečník J. Svalová biopsie v deseti bodech. CeskSlov Neurol N 2018; 81(3): 358-361. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.